ScholarIQanswers from OpenAlex
Neijiang Normal University
InstitutionResearch output, impact & collaborations
Neijiang Normal University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Neijiang Normal University?
ScholarIQrecord summary
Neijiang Normal University is a research organisation in Neijiang, CN. OpenAlex records 6,836 works and 85,890 citations for it. 1,840 researchers list it as their most recent affiliation.
How many works does Neijiang Normal University have?
ScholarIQindexed works
Neijiang Normal University has 6,836 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Neijiang Normal University have?
ScholarIQcitation count
Neijiang Normal University has 85,890 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Neijiang Normal University?
ScholarIQresearcher count
Neijiang Normal University has 1,840 researchers in the ScholarIQ index.
What is the average h-index at Neijiang Normal University?
ScholarIQavg h-index
Neijiang Normal University has an average h-index of 10 in OpenAlex.
What is the ROR of Neijiang Normal University?
ScholarIQror
The ROR for Neijiang Normal University is on the source record.
What is the OpenAlex record for Neijiang Normal University?
ScholarIQopenalex
The OpenAlex for Neijiang Normal University is on the source record.
Who are the most-cited researchers behind Neijiang Normal University?
ScholarIQtop researchers by citations
What are the most-cited papers on Neijiang Normal University?
ScholarIQmost cited works
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data
Justin Guinney, Tao Wang, Teemu D. Laajala, Kimberly Kanigel Winner, J Christopher Bare, Elias Chaibub Neto, Suleiman A. Khan, Gopal Peddinti, Antti Airola, Tapio Pahikkala, Tuomas Mirtti, Thomas Yu, Brian M. Bot, Liji Shen, Kald Abdallah, Thea Norman, Stephen Friend, Gustavo Stolovitzky, Howard R. Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Yang Xie, Tero Aittokallio, Fang Liz Zhou, James C. Costello, Kald Abdallah, Tero Aittokallio, Antti Airola, Catalina Anghe, Helia Azima, Robert Baertsch, Pedro J. Ballester, Chris Bare, Vinayak Bhandari, Brian M. Bot, Cuong Cao Dang, Maria Bekker‐Nielsen Dunbar, Ann‐Sophie Buchardt, Ljubomir Buturović, Da Cao, Prabhakar Chalise, Junwoo Cho, Tzu‐Ming Chu, R. Yates Coley, Sailesh Conjeti, Sara Correia, James C. Costello, Ziwei Dai, Junqiang Dai, Philip Dargatz, Sam Delavarkhan, Detian Deng, Ankur Dhanik, Yu Du, Aparna Elangovan, Shellie D. Ellis, Laura L. Elo, Shadrielle M. G. Espiritu, Fan Fan, Ashkan B Farshi, Ana Alão Freitas, Brooke L. Fridley, Stephen Friend, Christiane Fuchs, Eyal Gofer, Gopalacharyulu Peddinti, Stefan Graw, Russ Greiner, Yuanfang Guan, Justin Guinney, Guo Jing, Pankaj Gupta, Anna I Guyer, Jiawei Han, Niels Richard Hansen, Billy HW Chang, Outi Hirvonen, Barbara Huang, Chao Huang, Jinseub Hwang, Joseph G. Ibrahim, Vivek Jayaswa, Jouhyun Jeon, Zhicheng Ji, Deekshith Juvvadi, Sirkku Jyrkkiö, Kimberly Kanigel-Winner, Amin Katouzian, Marat D. Kazanov, Suleiman A. Khan, Shahin Khayyer, Dalho Kim, Agnieszka Kitlas Golińska, Devin C. Koestler, Fernanda Kokowicz, Ivan Kondofersky, Norbert Krautenbacher, Damjan Krstajić
Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis
Xiaohui Xie, Qiurong Fu, Ziwei Bao, Yi Zhang, Dan Zhou
The impact of smoking status on the progression‐free survival of non‐small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta‐analysis
Xinyi Li, Cong Huang, Xiaohui Xie, Ziyang Wu, Xia Tian, Yibo Wu, Xin Du, Luwen Shi
Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study
Lei Zhao, Nijia Chang, Lei Shi, Fengyi Li, Fanglin Meng, Xiaohui Xie, Zhe Xu, Fu‐Sheng Wang
Continuous Versus Intermittent use of Furosemide in Patients with Heart Failure and Moderate Chronic Renal Dysfunction
Zhigui Zheng, Xinxin Jiang, Jianguo Chen, Dongyuan He, Xiaohui Xie, Yunan Lu
How much of the research on Neijiang Normal University is open access?
ScholarIQopen access share
80%OPEN ACCESS